Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $55.92 million. The enterprise value is $53.02 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SER has 9.93 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 9.93M |
| Shares Outstanding | 9.93M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -15.23% |
| Owned by Insiders (%) | 30.19% |
| Owned by Institutions (%) | 5.53% |
| Float | 2.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,118.89 |
| Forward PS | n/a |
| PB Ratio | 84.45 |
| P/TBV Ratio | 33.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,039.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.45 |
| Quick Ratio | 1.81 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -135.82% |
| Return on Invested Capital (ROIC) | -279.04% |
| Return on Capital Employed (ROCE) | -436.38% |
| Revenue Per Employee | $3,923 |
| Profits Per Employee | -$72,231 |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.27% |
| 50-Day Moving Average | 5.15 |
| 200-Day Moving Average | 5.93 |
| Relative Strength Index (RSI) | 52.25 |
| Average Volume (20 Days) | 10,160 |
Short Selling Information
The latest short interest is 25,087, so 0.25% of the outstanding shares have been sold short.
| Short Interest | 25,087 |
| Short Previous Month | 31,255 |
| Short % of Shares Out | 0.25% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, SER had revenue of $51,000 and -$939,000 in losses. Loss per share was -$0.10.
| Revenue | 51,000 |
| Gross Profit | -7.43M |
| Operating Income | -19.11M |
| Pretax Income | -890,146 |
| Net Income | -939,000 |
| EBITDA | -18.92M |
| EBIT | -19.11M |
| Loss Per Share | -$0.10 |
Full Income StatementBalance Sheet
The company has $4.27 million in cash and $227,000 in debt, giving a net cash position of $4.04 million or $0.41 per share.
| Cash & Cash Equivalents | 4.27M |
| Total Debt | 227,000 |
| Net Cash | 4.04M |
| Net Cash Per Share | $0.41 |
| Equity (Book Value) | 1.56M |
| Book Value Per Share | 0.17 |
| Working Capital | 3.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.88 million and capital expenditures -$8,000, giving a free cash flow of -$17.16 million.
| Operating Cash Flow | -19.88M |
| Capital Expenditures | -8,000 |
| Free Cash Flow | -17.16M |
| FCF Per Share | -$1.73 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -37,468.63% |
| Pretax Margin | -1,988.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |